中国生物制药以68亿人民币收购礼新医药95.09%股权,创下2025年国内创新药并购新纪录,标志本土大型制药公司主动整合生物技术公司时代开启,此次并购为投资人开辟退出通道,验证创新药企市场价值。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.